Public Health Paramount: Delhi HC Upholds FSSAI’s Action Against Misleading ‘ORS’ Product Labeling
The Delhi High Court has upheld the Food Safety and Standards Authority of India (FSSAI)’s regulatory action against a company for misleading labeling and marketing of an ‘ORS’-branded product, emphasizing that public health must take
The Delhi High Court has upheld the Food Safety and Standards Authority of India (FSSAI)’s regulatory action against a company for misleading labeling and marketing of an ‘ORS’-branded product, emphasizing that public health must take precedence over commercial interests.
The court ruled that the product in question did not meet the prescribed standards for Oral Rehydration Salts (ORS) as defined under the Food Safety and Standards (Food Products Standards and Food Additives) Regulations, 2011. The manufacturer had allegedly marketed a flavored beverage as an ORS formulation, misleading consumers into believing it offered therapeutic benefits for dehydration.
In its judgment, the High Court stated that the integrity of health-related product labeling is crucial to public trust and safety, noting that improper use of terms like “ORS” can pose serious health risks, especially to children and patients suffering from diarrhea or dehydration.
Justice [Name], who delivered the verdict, observed, Public health considerations must override business interests. Misleading health-related claims cannot be tolerated, particularly when they exploit consumer trust and endanger vulnerable populations.”
The FSSAI’s enforcement drive against misleading food and nutraceutical labeling has intensified in recent years, focusing on products falsely claiming medical or nutritional benefits without scientific validation.
Legal experts have hailed the ruling as a landmark precedent for health-centric regulation, reinforcing the government’s stance on truthful labeling, responsible marketing, and consumer safety.
The decision is expected to strengthen ongoing regulatory efforts to curb deceptive health claims and ensure that only medically approved formulations* can be marketed under therapeutic or nutritional categories.
As India’s wellness and nutraceutical markets expand rapidly, the judgment reaffirms that “public health is non-negotiable”, setting a firm tone for accountability and ethical compliance in food and health product marketing.
